Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib

Pharmacology, Toxicology and Pharmaceutical Science

• Solitary Fibrous Tumor 100%
• Trabectedin 80%
• Ponatinib 80%
• Protein Tyrosine Kinase Inhibitor 40%
• Dasatinib 40%
• Protein 20%
• Diseases 20%
• Drug 20%
• Base 20%
• Rare Disease 20%
• Cell Culture 20%
• Sarcoma 20%
• Pharmaceutical Therapy 20%

Biochemistry, Genetics and Molecular Biology

• Ponatinib 80%
• Tyrosine Kinase Inhibitor 40%
• Growth 40%
• Dasatinib 40%
• STAT6 40%
• Cell Culture 20%
• Cell Viability 20%
• Experience 20%
• Regulatory Mechanism 20%
• Protein 20%
• Clonogenesis 20%